Virpax Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Virpax Pharmaceuticals shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Virpax Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Virpax Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Virpax Pharmaceuticals by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $2.1k | 6.6k | 0.32 |
2023-09-30 | $93 | 118 | 0.80 |
2022-12-31 | $7.3k | 12k | 0.62 |
2022-09-30 | $7.0k | 6.3k | 1.11 |
2021-12-31 | $39k | 11k | 3.43 |
2021-06-30 | $18k | 3.9k | 4.57 |
2021-03-31 | $14k | 3.0k | 4.70 |